OncoLens, a leader in optimizing cancer treatment planning, announced it has raised $16 million in a Series B round co-led by BIP Capital and Cross Border Impact Ventures. Martin Ventures and SeedToB, existing investors in the company, also participated in this round. ATLANTA, Oct. 24,...
Oncology Health Tech Startup Announces Series B Funding Round for Continued Growth of Cancer Treatment Platform and Research Network
Seaking AlphaSeeking Alpha / Seaking Alpha 22 hours ago 1 Views
Comments